NXGB: Acquires Patent Application for Breast Cancer Stem Cell Treatment (Nasdaq)

NXGB: Acquires Patent Application for Breast Cancer Stem Cell Treatment (Nasdaq)
NextGen Bioscience, Inc. (NXGB) has acquired use, commercialization and ownership rights of a patent application for the treatment of cancer from Oxon Life Science Inc.